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Abstract
Background: Scorpion toxins are invaluable tools for ion channel research and are potential drugs for human
channelopathies. However, it is still an open task to determine the molecular basis underlying the diverse
interactions between toxin peptides and ion channels. The inhibitory peptide Maurotoxin (MTX) recognized the
distantly related IKCa and Kv1.2 channel with approximately the same potency and using the same functional
residues, their differential binding mechanism remain elusive. In this study, we applied computational methods to
explore the differential binding modes of MTX to Kv1.2 and IKCa channels, which would help to understand the
diversity of channel-toxin interactions and accelerate the toxin-based drug design.
Results: A reasonably stable MTX-IKCa complex was obtained by combining various computational methods and
by in-depth comparison with the previous model of the MTX-Kv1.2 complex. Similarly, MTX adopted the b-sheet
structure as the interacting surface for binding both channels, with Lys23 occluding the pore. In contrast, the other
critical residues Lys27, Lys30, and Tyr32 of MTX adopted distinct interactions when associating with the IKCa
channel. In addition, the residues Gln229, Ala230, Ala233, and Thr234 on the IKCa channel turret formed polar and
non-polar interactions with MTX, whereas the turret of Kv1.2 was almost not involved in recognizing MTX. In all,
the pairs of interacting residues on MTX and the IKCa channel of the bound complex indicated that electrostatic
and Van der Waal interactions contributed equally to the formation of a stable MTX-IKCa complex, in contrast to
the MTX-Kv1.2 binding that is dominantly mediated by electrostatic forces.
Conclusions: Despite sharing similar pharmacological profiles toward both IKCa and Kv1.2 channels, MTX adopted
totally diverging modes in the two association processes. All the molecular information unveiled here could not
only offer a better understanding about the structural differences between the IKCa and Kv1.2 channels, but also
provide novel structural clews that will help in the designing of more selective molecular probes to discriminate
between these two channels.
Background
Scorpion venoms produce a large variety of peptide tox-
ins that target ion channels [1-5]. Especially, the wide-
spread use of scorpion-venom peptides acting on K
+-
channels as neuroscience tools and excellent ligand
models has tremendously increased our knowledge in
many fields, including exploration of the 3-dimensional
structures and elucidation of the pharmacological
characteristics of K
+ channels [4,6-8]. In addition, pep-
tide toxins are increasingly recognized as valuable
sources of new drugs for channelopathies [9,10].
Although natural toxins often lack sufficient efficacy and
specificity toward an individual channel type, most pep-
tide toxins adopt a cysteine-stabilized a/b scaffold; thus,
they could serve as good candidates for further struc-
ture-based drug design [4,10]. However, crystal struc-
tures for many medically important potassium channels
have not been determined, which makes the rational
designing of K
+-channel modulators difficult. Therefore,
applying computational methods to model reasonably
stable structures of channel-peptide toxin complexes
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any medium, provided the original work is properly cited.could be a good alternative, which would greatly help to
highlight the diversity of channel-toxin interactions and
provide structural information for toxin-based drug
design.
The intermediate-conductance calcium-activated
potassium channels (IKCa) act as positive modulators of
cell proliferation by hyperpolarizing the cell membrane
in T and B cells, fibroblasts, and vascular smooth mus-
cle cells [11-13]. Furthermore, blocking of IKCa channels
has been shown to be a potential therapeutic strategy
against autoimmune disorders involving these tissues
[13-15]. However, almost all the peptidic and small
molecular IKCa blockers could not discriminate well
between the IKCa channel and other related Kv-family
channels and, thus, lack the specificity needed for
further drug development [12,13,15,16].
Maurotoxin (MTX), a peptide derived from the venom
of the scorpion Scorpio maurus palmatus, is the most
potent peptidic blocker of the IKCa channel [17,18]. In
addition, MTX could distinguish the IKCa channel from
the other calcium-activated channels and the Kv1-family
channels, except for the voltage-gated Kv1.2 channel
[17-21]. Interestingly, although the IKCa channel is
entirely different from the Kv1.2 channel in tissue con-
tribution and physiological function [11,12,15,16], MTX
shows very similar pharmacological profiles in recogniz-
ing these two channels with approximately the same
potency and using the same functional residues
[17,18,21]. In this study, we aimed to interpret the dif-
ferential binding mechanisms of MTX with reference to
the IKCa and Kv1.2 channels, which would provide a
deep insight into the topological differences of these two
channels and offer important clues for designing inhibi-
tors that are more selective toward the therapeutic IKCa
channel.
Combined computational methods were used to inves-
tigate the details of the interactions between MTX and
the IKCa channel; the structural details were further
compared with the previous model of the MTX-Kv1.2
complex [22]. A stable structure of the MTX-IKCa com-
plex was obtained by using ligand docking, clustering
analysis, and molecular dynamics simulation (MDS)
methods. The validity of the final MTX-IKCa complex
was supported by good accordance between the compu-
tational alanine-scanning results and the experimental
data. On comparison, although with similar pharmacolo-
gical profiles, MTX adopted very different modes for
associating with the IKCa and the Kv1.2 channels. In
both MTX-IKCa and MTX-Kv1.2 complexes, MTX
adopted the b-sheet domain as the interaction surface
with the Lys23 occluding the pore. However, the other
key residue, Tyr32, was positioned quite differently in
these two complexes. Meanwhile, the turret region of
the IKCa channel played an important role in binding
with MTX, which is different from the noninvolvement
of the Kv1.2 turret during interaction with MTX. In
addition, due to the different physicochemical profiles of
the two channels, electrostatic and van der Waals (vdW)
interactions made different contributions to the free
energies of binding in MTX-Kv1.2 and MTX-IKCa com-
plexes. All these structural and energetic discrepancies
constitute the key determinants responsible for the
binding specificity of MTX to the IKCa and Kv1.2 chan-
nels, which could help design MTX derivatives that
would discriminate between these two channels.
Results and Discussion
Different MTX binding modes towards IKCa and Kv1.2
channels
Given the similar blocking activities that MTX showed
toward IKCa and Kv1.2 channels [17,18], we first tested
whether MTX recognized the IKCa channel in the same
binding mode as for the Kv1.2 channel. An MTX-IKCa
complex was modeled on the basis of the MTX-Kv1.2
complex structure [22] using the distance-restraint
homologous modeling method and then subjected to
unrestrained MDS to test its stability. Previously, MTX
adopted the b-sheet domain as the interacting surface,
with Lys23 occluding the pore of the Kv1.2 channel
(Figure 1A, left panel). And the most important residue,
Tyr32, of MTX kept sticking into the pocket formed
Figure 1 The stability of an MTX-IKCa candidate that resembles
the MTX-Kv1.2 complex. (A) The structural comparison of the
MTX-Kv1.2 complex before and after 8-ns unrestrained MDS. (B) The
structural comparison of the MTX-Kv1.2-like candidate for the MTX-
IKCa complex before and after 4-ns unrestrained MDS. Complexes
before and after MDS are distinguished by colors. (C) The RMSd
fluctuation of MTX (left), IKCa (middle) and complex (right) of the
MTX-Kv1.2-like candidate for the MTX-IKCa complex in 4-ns MDS.
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Kv1.2 channel during the 8-ns production run [22]
(Figure 1A). Thus, the interaction between MTX and
the Kv1.2 channel was beneficial for the stability of the
turret region. On the contrary, in the MTX-IKCa com-
plex, in spite of starting from a similar conformation
of sticking into the pocket formed by the turret and
the pore region (Figure 1B, left panel), the Tyr32 was
unwelcome in this position and gradually bent away
from the “pocket” after 4-ns MDS (Figure 1B, middle
panel). Therefore, the experimentally important resi-
dues, Lys23 and Tyr32, failed to form strong interac-
tions with the channel, and MTX deviated from the
central position (Figure 1B, right panel). As a result,
the turret on the other side of the IKCa channel failed
to maintain stability and bent outward (see Figure 1C
t h eR M S Do fI K C ac h a n n e l ) .O b v i o u s l y ,t h i sc o m p l e x
structure could not explain the experiment results at
all. Therefore, although MTX showed similar pharma-
cological profiles toward both Kv1.2 and IKCa channels,
it did not use the same binding mode in associating
with these two channels.
MTX-IKCa complex from docking and MDS
We next applied a routine molecular docking and clus-
tering analysis to screen plausible MTX-IKCa complexes
[22-25]. All the 35 nuclear magnetic resonance confor-
mations of MTX with different side-chain positions
were used in the ZDOCK program, and 35, 000 com-
plexes were generated in total.
The 35, 000 MTX-IKCa complexes fell into four main
binding modes, according to the orientation of the
MTX b-sheet domain (Figure 2, top panel). As indi-
cated in our previous study, the starting position of
the residue Tyr32 of MTX is essential for obtaining a
final stable complex [22]. Thus, we mapped all possible
orientations of the aromatic ring of Tyr32 in the four
groups of complexes (Figure 2, middle panel), includ-
ing the following: (1) lying slantways over the linker
connecting S6 and the selectivity filter of the IKCa
channel; (2) hanging between two subunits of the
channel; (3) plugging the pore of the channel along
with Lys23; (4) hanging upr i g h to v e rt h el i n k e rc o n -
necting S6 and the selectivity filter of the IKCa channel.
Next, each of the candidates in the four binding modes
was subjected to energy minimization, followed by
500-ps unrestrained MDS, to introduce more flexibility
and investigate the potential structural fluctuations.
For better discrimination among the four binding
modes, the alanine-scanning method in the MM-GBSA
of Amber-8 was applied for comparison of the compu-
tational and experimental data of functional residues
(Figure 2, bottom panel). Finally, an MTX-IKCa model
that best fit the experimental data was selected from
the binding mode II. To make it more equilibrated and
stable, the selected MTX-IKCa model was subjected to
a further 10-ns unrestrained MDS (Figure 3A).
According to the major transitions during the MDs,
we also evaluated the free energy convergence by sam-
pling along the whole simulation (Figure 3B). The
results showed that both the peptide and the channel
were induced to fit in their nanosecond-scale diffu-
sional encounter, and then guided to form a specific
stable complex.
To check the confidence of our MTX-IKCa model, the
ΔΔGbinding of eight single mutations of MTX were cal-
culated and compared with the experimental data
[17,18]. An overall high degree of correlation was found
between the calculations and the experiments involving
mutational effects (Figure 3C). Replacing the Lys23 resi-
due of MTX with alanine caused the most noticeable
decrease of 4.4 kcal/mol in the calculated binding
energy, which is well in accordance with the experimen-
tal data of 4.32 kcal/mol. Substitution of another impor-
tant residue, Tyr32, with alanine significantly reduced
the MTX affinity by over 1000 fold [18], and the calcu-
lated ΔΔGbinding value of 4.31 kcal/mol corresponded
well with the experimental data of 4.21 kcal/mol. How-
ever, MTX affinity for IKCa was decreased by less than
10 fold by the S2A, T4A, S6A, K7A, Y10A, and G33A
mutants [18]. This is strongly supportive for the little
change in binding energy when these residues were
Figure 2 Structural view of the four selected MTX-IKCa channel-
binding modes along with the comparison of the calculated
and experimental effects. Each row of figures is as follows: (top)
the different spatial orientations of MTX in its complex with the IKCa
channel from four main binding modes; (middle) the representative
positions of the Lys23 and Tyr32 side chains in four main binding
modes distinguished by different colors; (bottom) the comparison
of the calculated and experimental effects for the five alanine
mutations of MTX on the binding affinity toward the IKCa channel
after 500-ps unrestrained MDS. The calculated results are normalized
values of ΔΔGbinding, whereas the experimental results are obtained
as kbT ln [IC50(mutant)/IC50(wt)].
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Lys7 were located at the N-terminal of MTX, whereas
Tyr10 was in the middle of the a-helix of MTX, all out-
side the interface of MTX.
Consistent with the findin g si np r e v i o u sd o c k i n g
experiments of MTX onto IKCa channel [26], in the
final MTX-IKCa complex, the peptide used its b-sheet as
the interacting surface, with Lys23 as a structurally con-
served pore-blocking residue (Figure 3D). This phenom-
enon was also observed when MTX associated with the
Kv1.2 channel in both our study [22] and the previous
docking results by Visan [18]. All these studies under-
l i n et h ek e yr o l eo fM T Xb-sheet region in IKCa and
Kv1.2 channel recognition. Interestingly, such impor-
tance is strongly supported by the previous experimental
data that when substituting the b-sheet region of MTX
with that of another toxin, HsTX1, its activity toward
the two channels almost disappeared [27].
Despite that MTX used the b-sheet to interact with
both IKCa and Kv1.2 channels, when analyzing the con-
formation of other bioactive residues, the molecular
information for the recognition of IKCa by MTX showed
several distinct features, compared to those for the
Kv1.2 channel.
Differential molecular information contained by Tyr32
and Lys7 in MTX
The mutant-cycle experiment showed that two major
functional residues, namely, Lys23 and Tyr32, in MTX
block the IKCa channel [17,18]. The key role of these
residues can be shown by their structural conformation
in the final MTX-IKCa complex. Although the pore-
blocking characteristic ofL y s 2 3w a sc o m m o nw h e n
MTX recognized both the IKCa and the Kv1.2 channels,
the conformation of Tyr32 of MTX differed greatly in
each of these contexts (Figure 4A, B). As indicated in
the second section, the residue Tyr32 is essential for
MTX-associating potassium channels, and its position
was proposed to be the main factor determining the sta-
bility of the complex structure after a long-term unrest-
rained production run. In the final MTX-IKCa complex,
the favorable position for the residue Tyr32 was lying
on the linker connecting the selectivity filter and the S6
helix of the channel, forming strong polar and nonpolar
interactions with Gly254 (D chain), Asp255 (C and D
chains), Val256 (D chain), and Val257 (D chain) on the
pore region of the channel (Figure 4A). In comparison,
the Tyr32 in the MTX-Kv1.2 complex, however, differed
significantly from that in the MTX-IKCa complex by
sticking into the pocket formed by Arg354 and F358 on
the turret and Asp379, Met380, Val381, and Thr383 on
t h ep o r er e g i o no ft h eK v 1 . 2c h a n n e l[ 2 2 ]( F i g u r e4 B ) .
Thus, the differential chemical environment for Tyr32
contributed greatly to the different binding modes
Figure 3 The stability and validity of the final MTX-IKCa
complex. (A) Root-mean-square deviations (Å) of the a-carbons in
the final MTX-IKCa complex from the starting complex during the
10-ns unrestrained MD simulations. (B) The free energy convergence
during the 10-ns unrestrained MD simulations, trajectories were
sampled every ns along the simulation time. (C) Calculated and
experimental effects for 5 single-alanine mutations on the blocking
activity of MTX toward the IKCa channel after 10-ns MDS. The
calculated results are normalized values of ΔΔGbinding, whereas the
experimental results are obtained as kbT ln [IC50(mutant)/IC50(wt)].
(D) An overview of the final model of the MTX-IKCa complex, with
the labels of all the experimentally determined residues.
Figure 4 The distinct recognition mechanisms of MTX toward
the IKCa and Kv.1.2 channels. (A), (C) Interaction details of Tyr32
and Lys7 of MTX in the MTX-IKCa complex within a contact distance
of 5Å, respectively. (B), (D) Interaction details of Tyr32 and Lys7 of
MTX in the MTX-Kv1.2 complex within a contact distance of 5Å,
respectively.
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channels.
In addition, rather than forming strong electrostatic
interactions with the aspartic acid residues in the pore
region of the channel, the side chain of the Lys7 of
MTX pointed to an opposite orientation from the IKCa
channel, contacting no residue of the channel within a
5-Å distance (Figure 4C). This is different from the
result of the mutant-cycle anal y s i st h a tL y s 7i ss i t u a t e d
n e a rt h eA s p 2 3 9o ft h eI K Ca channel [17,18]. However,
as the K7A mutation only affected the blocking activity
of MTX by less than 10 fold [17,18], it is possible that
the Lys7 just faced its alternative partner Asp239 in the
interface reorganization process, but does not contact
Asp239 directly in the final conformation. Such a posi-
tion of the Lys7 while associating with the IKCa channel
differed significantly from that in the MTX-Kv1.2 com-
plex, in which the Lys7 formed strong polar interactions
with the Asp373 at the pore region of the channel [22]
(Figure 4D). This distinctness was in consistence with
the experimental data that the blocking activity of the
MTX-K7A mutant decreased by about 100 fold in the
case of the Kv1.2 channel, but decreased by only less
than 10 fold in the case of the IKCa channel [18].
Differential molecular information of other residues in
MTX
Considering that the b-sheets of MTX constitute its
main channel-interacting surfaces, two other residues
Lys27 and Lys30 were also found to play outstanding
roles in the recognition process (Figure 5A, B). In the
model of the MTX-IKCa complex, the Lys30 mainly
interacted with Gly254 (D chain) and Val257 (A chain)
at the pore region of the IKCa channel (Figure 5A); in
addition, it also formed some electrostatic interactions
with the backbone of Asp255 (D chain). Another basic
residue Lys27, however, did not electrostatically interact
with any acidic residues of the channel, but rather stuck
into a pocket formed mostly by nonpolar residues,
including Thr234 and Trp221 on the turret; and Val256,
Val257, and Pro258 on the linker connecting the S6
helix and the selectivity filter (Figure 5A). Such finding
is completely in line with the previous docking result of
MTX onto IKCa channel [26], which highlighted the
important contribution of Lys27 and Lys30 in the inter-
action, due to their proximity to Asp255, Val257 and
Asp239 of the channel.
However, these interaction modes mediated through
L y s 2 7a n dL y s 3 0o ft h eM T Xi nr e c o g n i z i n gt h eI K Ca
channel differed obviously from those involving MTX
and the Kv1.2 channel, in which both Lys27 and Lys30
formed strong polar interactions with the channel [22].
Within a contact distance of 5Å, the Lys27 and Lys30 of
MTX, respectively, contacted closely with the conserved
acidic residue, Asp379, in the pore region of the Kv1.2
channel and formed strong electrostatic interactions
(Figure 5B).
The different functional roles for the Lys27 and Lys30
of MTX when recognizing the IKCa and the Kv1.2 chan-
nels could be further illustrated by calculating their
mutation effects. As indicated in Table 1, either chan-
ging Lys27 or Lys30 of MTX into alanine resulted in a
big change in the MTX-IKCa and MTX-Kv1.2 interactive
energies. However, in the model of the MTX-IKCa com-
plex, the changes in the vdW energies and electrostatic
energies almost synergistically contributed to the large
values of the altered interactive energies when replacing
Lys27 with alanine (Table 1), in accordance with the
observation that the Lys27 of MTX mainly interacted
with the nonpolar residues in IKCa channel. In contrast,
in the MTX-Kv1.2 complex, the increase in the interac-
tive energies caused by mutating Lys27 and Lys30 were
both dominantly constituted by the significant change in
the electrostatic energies (Table 1), resulting from the
interacting residue pairs Lys27-Asp373 and Lys30-
Asp379 (Figure 5B).
Distinct channel vestibules constitute different
recognition modes toward maurotoxin
The a-KTx family of K
+-channel blockers has been
proved to function as informative molecular probes for
the structure-function analysis of K
+ channels. Although
the IKCa and Kv1.2 channels have distinct tissue
Figure 5 The comparison for the pairs of MTX-IKCa and MTX-
Kv1.2 interacting residues in the bound complexes. Lys27 and
Lys30 of MTX are surrounded by residues from the IKCa channel (A)
and Kv1.2 channel (B) within a distance of 5Å, respectively.
Table 1 Effects of K27A and K30A mutants on interactive
energies (Kcal/mol)
Energies MTX-IKCa MTX-Kv1.2
Mutants ΔEvdW ΔEele ΔEinter ΔEvdW ΔEele ΔEinter
WT -78.65 -118.21 -196.86 -74.06 -1577.51 -1651.57
MTX_K27A -74.31 -110.24 -184.55 -61.62 -1361.07 -1422.69
MTX_K30A -73.51 -73.07 -146.58 -57.01 -1354.70 -1411.71
Interactive energies (kcal/mol) were calculated using the MM-GBSA program
in Amber-8.
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be blocked by MTX with a similar pharmacology profile.
Thus, identifying the differential determinants that are
responsible for the MTX binding of the IKCa and Kv1.2
channels could help discover the different topologies of
a mechanistically interesting part of these two channels:
the outer vestibule of the ion-conduction pore.
Sequence comparison showed that the IKCa channel
has a longer turret region than the Kv1.2 channel, and
the sequence identity is rather low (Figure 6A). These
features were further shown by the structural analysis of
unbound IKCa and Kv1.2 channel vestibules (Figure 6B),
whereas the differential conformation of the channel tur-
ret suggested a different functional role for the channel
vestibule during the toxin-recognition process. This
hypothesis was supported by comparing our model of the
IKCa-MTX complex with the previous Kv.1.2-MTX
model [22] (Figure 6C, D). We mapped all the toxin-
interacting residues in the IKCa channel turret (see Figure
6C and additional file 1: Figure S1) and found that the
channel turret played an important role in stabilizing the
final IKCa-MTX complex. Four residues, Gln229, Ala230,
Ala233, and Thr234 in the IKCa turret formed polar and
non-polar interactions with the corresponding residues
of MTX. Interactions have been found between Gln229
of IKCa and Gly18, Pro20 of MTX, Ala230 of IKCa and
Pro20 of MTX, Ala233 of IKCa and Val1, Thr17 of MTX,
Thr234 of IKCa and Lys27, Tyr32, Gly33 of MTX, respec-
tively. Thus, the important role of the IKCa channel’st u r -
ret in recognizing MTX is in sharp contrast with the
almost nil involvement of the Kv1.2 channel turret,
b e c a u s eo n l yt h eT y r 3 2o fM T Xw a sa b l et oc o n t a c tt h e
Kv1.2 turret within the distance of 5Å (Figure 6D) and
several mutations on the Kv1.2 channel turret hardly
affected the binding affinity of MTX [18,22]. In addition,
it is noticeable that the total net charge of the turret of
the IKCa channel is almost neutral, due to the average
distribution of positive and negative residues in the turret
(Figure 6A, E). This is very different compared with the
Kv1.x family, all of which contained four extremely nega-
tive-charged turrets (Figure 6A, F). Actually, the IKCa
channel turret, with an important functional role and
neutral charge, could well explain the equal contribution
of electrostatic and vdW interactions in mediating the
recognition process between the IKCa channel and MTX
(Table 2), and the highly negative-charged Kv1.2 turrets
are responsible for the dominance of electrostatic recog-
nition in the binding of MTX to the Kv1.2 channel
(Table 2). All these data suggest that the diverse vesti-
bules of the IKCa and Kv1.2 channels, including the
sequence length, sequence identity, vestibule conforma-
tion, and property of molecular surface jointly determine
their different interaction modes.
Figure 6 The comparison for the sequence, conformation, and
functional role of the outer vestibules of the IKCa and Kv1.2
channels. (A) Sequence alignment for the outer vestibule of the IKCa
and Kv1.2 channels. The conserved residues are grey-shaded, acidic
residues red-shaded, basic residues blue-shaded. (B) Left and right
are, respectively, the side and top views of the ribbon structures of
the outer vestibules of the IKCa and the Kv1.2 channels, respectively.
The IKCa channel is pink-colored, and the Kv1.2 channel is green-
colored. For clarity, only two chains of the channels are shown in the
side view. (C), (D) Functional roles for the turrets of the IKCa and Kv1.2
channels, respectively, in associating with MTX, respectively. All the
toxin-interacting residues within a contact distance of 5Å are labeled
on the turret of the IKCa and Kv1.2 channels. (E), (F) Stereoview
displaying the molecular surfaces of the IKCa and Kv1.2 channels,
respectively. The molecular surfaces are colored according to their
electrostatic potentials, with basic residues in blue, acidic residues in
red, and neutral residues in white.
Table 2 Different polar and nonpolar contributions to the
binding free energies in MTX-IKCa and MTX-Kv1.2
complexes
Complex ΔEelec ΔEvdW ΔEinter ΔΔGGB ΔΔGSA ΔG*binding
MTX-IKCa -118.21 -78.65 -196.86 163.92 -10.59 -43.53
MTX-Kv1.2 -1577.51 -74.06 -1651.57 1616.66 -10.55 -45.46
Binding free energies (kcal/mol) were calculated using the MM-GBSA program
in Amber-8.
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Through combined computational methods, including
ZDOCK, clustering analysis, and MDS, a reasonably
stable MTX-IKCa complex structure was obtained.
Further study of this structure showed that in spite of
sharing similar pharmacological profiles toward both
IKCa and Kv1.2 channels, MTX associated with the IKCa
channel in a quite different mode compared to that of
MTX interacting with the Kv1.2 channel. In the bound
complex, MTX assumed the b-sheet domain as the
interaction surface with the Lys23 occluding the pore of
the IKCa channel in a manner similar to its interaction
with the Kv1.2 channel. However, the conformation of
another key residue Tyr32, which was the key to the sta-
bility of the complex structure, differed greatly when
MTX recognized the IKCa channel, compared to the
process with the Kv1.2 channel. It continued lying on
the linker connecting the selectivity filter and the S6
helix of the IKCa channel, forming strong polar and non-
polar interactions with residues on the pore region of
the channel. In addition, the Lys7 of MTX is possibly
involved in the toxin-channel interface reorganization
process; however, it does not contact any residues of the
IKCa channel directly in the final conformation. This is
in contrast with the fact that the Lys7 of MTX formed
strong polar interactions with the Asp373 at the pore
region of the Kv1.2 channel. In addition, electrostatic
and vdW interactions contributed equally to the binding
of MTX with IKCa, whereas the MTX-Kv1.2 association
featured dominant electrostatic contribution. Such con-
formational and energetic differences in recognition
could be well explained by the different functional roles
of the channel vestibules. The longer, neutral-charged
IKCa channel turret played an important role in stabiliz-
ing the final IKCa-MTX complex, with four residues–
Gln229, Ala230, Ala233, and Thr234 forming polar and
non-polar interactions with MTX. On the contrary, the
shorter Kv1.2-channel turret is highly negatively charged
and is barely involved in recognizing MTX. In all, the
differences in the binding mechanisms of MTX toward
the IKCa and Kv1.2 channels unveiled in this study
could offer a better understanding of the physicochem-
ical properties and conformational distinctness of the
two channels and thus give a hint for designing MTX-
derived inhibitors to discriminate between these two
channels.
Methods
Atomic Coordinates and Molecular Docking
The atomic coordinates of MTX (PDB code: 1TXM)
were downloaded from the PDB [28]. The previous seg-
ment-assembly homology model was applied to obtain
the structure of the pore region of the IKCa channel
[24]. This model was then subjected to 5-nanosecond
(ns) MDS for equilibration.
To improve the docking performance, all 35 conforma-
tions of MTX were used to dock with the equilibrated
IKCa structure through the ZDOCK program [29], a fast
Fourier transform (FFT)-based, initial-stage rigid-body
molecular-docking algorithm. Each docking produced
1000 candidate complexes, thus 35000 candidate MTX-
IKCa complexes were obtained and used for the clustering
analysis. According to the orientation of the MTX b-sheet
domain, the 35000 complexes were then divided into four
main binding modes. Clustering analysis and experimental
data-based screening [17,18] were then carried out on all
the complexes to select the possible hits from all modes.
Candidates from each binding mode were then subjected
to a 500-step energy minimization using the Sander mod-
ule of the Amber-8 suit of programs [30]. By calculating
the ligand-receptor binding energies with the ANAL pro-
gram of Amber-8, appropriate candidate complexes were
identified for further MDS study.
MDS study
All the simulations in this work were carried out using the
Amber-8 program [30] on a 64-CPU Dawning TC4000L
cluster (Beijing, China). The generalized Born model [31],
which has been successfully used to study other toxin-
channel interactions [22,24,25,32,33], was applied in this
study.
All the candidate complexes selected by the screening
process went through 400-picosecond (ps) equilibration
and 500-ps unrestrained simulations to introduce more
flexibility. The equilibration steps were taken by gradu-
ally reducing the force constant–from 5.0 (kcal/mol)/Å
2
for restraining all the heavy atoms, to 0.02 (kcal/mol)/Å
2
for heavy atoms of the backbone only. The temperature
was set at 300 K, with a cutoff distance of 12 Å. For the
most reasonably stable complex selected after a 500-ps
unrestrained simulation, an additional 10-ns unrestrained
simulation was conducted to introduce enough flexibility
and to probe into the interaction details. Throughout all
the energy minimization and simulation processes, the
ff99 force field (Parm 99) [34] was applied.
During the simulation, the membrane around the chan-
nel has not been taken into account. It is because that the
scorpion peptide binds to the extracellular part of the
channel according to mutagenesis studies and solid-state
NMR results [6,35-37], where the interaction is hardly
affected by the membrane and the transmenbrane segment
of channel. Other study groups have also used the same
membrane-ignoring measures in molecular simulation stu-
dies of toxin-channel interactions [22-25,32,33,38-40].
However, the importance of the membrane in the func-
tioning of channels has been increasingly recognized. A
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the role of the membrane were taken into account.
Calculation of Free energy of Binding by the Molecular
mechanics–Generalized Born Surface Area method
In the molecular mechanics–generalized born surface
area (MM-GBSA) method of AMBER-8 [30], the free
energy of binding of the reaction A + B ® AB is calcu-
lated using the following thermodynamic cycle:
ΔΔ Δ Δ Δ
ΔΔ Δ
GG G G G
HT S G
binding gas Solv
A
solv
B
solv
AB
gas GBSA
A
=− − +
=− − − −+
=− + +
ΔΔ
Δ Δ ΔΔ ΔΔ
GG
HT SG G
GBSA
B
GBSA
AB
gas GB SA
(1)
ΔΔ ΔΔΔ HEE EE gas gas intra elec vdW ≈= ++ (2)
ΔΔ Δ Δ Δ GG GG GB GB
AB
GB
A
GB
B =− + () (3)
ΔΔ Δ Δ Δ GG GG SA SA
AB
SA
A
SA
B =−+ () (4)
where T is the temperature, S is the solute entropy,
ΔGgas is the interaction energy between A and B in the
gaseous phase, and ΔGsolv
A , ΔGsolv
B ,a n dΔGsolv
AB are the
solvation free energies of A, B, and AB, which are esti-
mated using the GBSA method [30]. That is,
ΔΔ Δ Δ Δ GGG G solv
AB
GBSA
AB
GB
AB
SA
AB =+ + ,a n ds of o r t h .ΔGGB
and ΔGSA are the electrostatic and nonpolar terms,
respectively. ΔEbond, ΔEangle,a n dΔEtorsion are contribu-
tions to the intramolecular energy ΔEintra of the com-
plex. EvdW is vdW interaction energy. Because of the
constant contribution of -TΔS for each docked complex,
we quote ΔG*binding for ΔGbinding + TΔS in the discus-
sion. To verify the quality and validity of the resulting
MTX-IKCa complexes, the relative free energy of bind-
ing, ΔG*binding, was calculated using MM-GBSA for
postprocessing-collected snapshots from the MD trajec-
tories. In this work, 30 snapshots from the last 30-ps
MDS were used for analysis of the free energy of
binding.
Additional material
Additional file 1: The interaction details between the D chain of
IKCa channel and MTX. (A) Gln229 on the channel turret interacts with
Gly18 and Pro20 of MTX. (B) Ala230 on the channel turret interacts with
Pro20 of MTX. (C) Ala233 on the channel turret interacts with Thr17 of
MTX. (D) Thr234 on the channel turret interacts with Tyr32 and Gly33 of
MTX.
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